APA

Kerem E., Hirawat S., Armoni S., Yaakov Y., Shoseyov D., Cohen M., Nissim-Rafinia M., Blau H., Rivlin J., Aviram M., Elfring G. L., Northcutt V. J., Miller L. L., Kerem B. & Wilschanski M. (20080909). Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. : Lancet (London, England).

Chicago

Kerem Eitan, Hirawat Samit, Armoni Shoshana, Yaakov Yasmin, Shoseyov David, Cohen Michael, Nissim-Rafinia Malka, Blau Hannah, Rivlin Joseph, Aviram Micha, Elfring Gary L, Northcutt Valerie J, Miller Langdon L, Kerem Batsheva and Wilschanski Michael. 20080909. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. : Lancet (London, England).

Harvard

Kerem E., Hirawat S., Armoni S., Yaakov Y., Shoseyov D., Cohen M., Nissim-Rafinia M., Blau H., Rivlin J., Aviram M., Elfring G. L., Northcutt V. J., Miller L. L., Kerem B. and Wilschanski M. (20080909). Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. : Lancet (London, England).

MLA

Kerem Eitan, Hirawat Samit, Armoni Shoshana, Yaakov Yasmin, Shoseyov David, Cohen Michael, Nissim-Rafinia Malka, Blau Hannah, Rivlin Joseph, Aviram Micha, Elfring Gary L, Northcutt Valerie J, Miller Langdon L, Kerem Batsheva and Wilschanski Michael. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. : Lancet (London, England). 20080909.